Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
Adrien Contejean(Centre Hospitalier Annecy Genevois), Flore Sicre de Fontbrune(Assistance Publique – Hôpitaux de Paris), Lionel Adès(Délégation Paris 7), Étienne Lengliné(Assistance Publique – Hôpitaux de Paris), Cécile Moluçon‐Chabrot(Centre Hospitalier Universitaire de Clermont-Ferrand), Luc‐Matthieu Fornecker(Hôpitaux Universitaires de Strasbourg), Matthieu Resche‐Rigon(Inserm), Delphine Lebon(Centre Hospitalier Universitaire Amiens-Picardie), Fiorenza Barraco(Hôpital Lyon Sud), Jean‐Yves Cahn, Louis Terriou(Centre Hospitalier Universitaire de Lille), Didier Bouscary(Université Paris Cité), Lucile Bussot(Centre Hospitalier Universitaire de Grenoble), Régis Peffault de Latour(Hôpital Saint-Louis), Fabrice Jardin(Laboratoire National Henri Becquerel), Laurence Simon(Sorbonne Université), Ambroise Marçais(Hôpital Necker-Enfants Malades), Gérard Socié(Délégation Paris 7), Pierre Hirsch(Inserm), Natacha Maillard(Centre Hospitalier Universitaire de Poitiers), Jérôme Tamburini(Centre National de la Recherche Scientifique), Anne Banos(Centre Hospitalier de la Côte Basque), Marion Alcantara(Hôpital Necker-Enfants Malades)
Cited by 34
Related Papers
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
|The Lancet Oncology|2014|703
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543